Answers are grounded in this paper and cite their sources.
Demonstrates barrier protection and reduced inflammation in EHEC-infected mice, suggesting a new treatment avenue.
. GHbK and GHb3K significantly decreased the disease activity index (DAI) in EHEC-infected mice in comparison with the untreated model group. The derived peptides exhibited barrier-protective effects by preserving structural integrity, reducing inflammatory infiltrates in the intestinal epithelium, and maintaining gut microbiota diversity. Taken together, GHbK and GHb3K exhibit promising anti-inflammatory and anti-infection potential against EHEC infection. These findings lay a foundation for exploring the application of antibacterial peptides in the treatment of EHEC infection.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: